<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170123032129N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-10-20</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>Effectiveness of an educational intervention (the Encourage Autonomous Self-Enrichment Program)  on self- management in Patients with high blood pressure</public_title>
      <acronym>EASE</acronym>
      <scientific_title>Effectiveness of an educational intervention (the Encourage Autonomous Self-Enrichment Program)  on self- management in Patients with high blood pressure referred to ّّFarshchian cardiac outpatient in Hamadan 2018.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/34116</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: After referring to the outpatient heart clinic for patients with hypertension and introducing them to the authorities, the samples will be selected first. having criteria for entering the study will be reviewed. then 35 cards with A letters and 35 cards with B letter will be placed inside sealed envelopes and each patient will select one of these cards randomly without placement, and if you select the letter A, will be In the test group and if the card is selected B, they will be in the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Primary blood pressure.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After registration of patients who want to participate in research projects. The goals and the process of research will be explained to them. Patient's informed consent will be filled out. If they have inclusion criteria, they participate in the study. demographic information will be taken. This study was designed as a simple randomized controlled etrial with  one-to-one allocation into two groups. The intervention group participated in the EASE program will be 35 and control group too.The EASE program in six steps is as follows for the intervention group: During step 1 of this program, information about the participant’s demographic characteristics, treatment plan, and examination data was gathered. The appropriateness of each patient’s medical care was confirmed, and participants were evaluated to ensure their psychological and physical preparedness. Client–professional relationship a major inﬂuence on healthcare behaviors (Interaction model) (First session).  In Step 2, nurses encouraged participants to independently clarify issues related to their lifestyle and determine the self-management techniques needed for a healthier lifestyle (Express the positive and negative issues of lifestyle in relation to blood pressure), and Self-management approaches to improve healthy lifestyles (The factors and behaviors that reduce the blood pressure and its complications will be named and appropriate answers will be encouraged) ( Promotion model, Self efficacy) (second session). In Step 3, participants were involved in the setting of specific goals to foster self-efficacy and received support for their autonomous achievement of these goals, as enhanced self-efficacy is thought to lead to behavioral changes (Self efficacy, Promotion model) (second session). In step 4, techniques for achieving these goals were selected. In this study, self-monitoring was used to monitor the participants' actions and emotions toward their goals. The participants used self-monitoring techniques that involved monitoring of their actions and related benefits, which were logged using monitoring notes. Other techniques were added according to the participant’s condition; these included behavioral reinforcement and incremental goal achievement (action goals were set using small steps that initiated from achievable goals). Encouraging achievements, planning minor goals for achieving success and gaining positive experiences, encouraging verbal and nonverbal ways to increase repetition of behavior, creating optimism and hope for breakthroughs that will all enhance patient self-efficacy ( Promotion model, Self efficacy) (The third and fourth sessions). For Step 5, the nurses supported the participants' achievements of their action goals through interviews (fifth meeting) and phone or e-mail communication that patients will be contacted for 3-5 weeks every three days every 10 to 10 minutes, and guidance and encouragement will be used to strengthen positive behaviors and will support the achievements of the participants in achieving the desired goals (Promotion model, Self efficacy). For step 6: Achieving the desired goals will be evaluated. After eight weeks from the completion of the study, the variables will be re-evaluated as self-report at the clinic's meeting for re-examination (sixth session). Intervention 2: 35 patients will be in control group. The control group won't participate in education sessions. The control group will receive routine education based on health centers program according to national protocols. At the first, control group will receive self-management, and self-monitoring of blood pressure questionnaires. Blood tests, Body Mass Index, blood pressure, will be measured too. After 3 months, the questionnaires,  Clinical blood tests and BMI, blood pressure will be done again.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is "No more information"</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>عظیم عزیزی</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hamadan University of Medical Science, Shahid Fahmide boulevard</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>00988138380150</zip>
        <telephone>+98 81 3838 0150</telephone>
        <email>a.azizi@umsh.ac.ir</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Azim Azizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>آدرس خیابان Hamadan University of Medical Science, Shahid Fahmide boulevard</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>00988138380150</zip>
        <telephone>+98 81 3838 0150</telephone>
        <email>a.azizi@umsh.ac.ir</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients have the ability to read and write
At least 6 months have been diagnosed with early onset and ongoing treatment
They are being treated for high blood pressure
Failure to participate in a co-effective study on study variables
Having the right physical conditions to attend training sessions
Ability to answer the phone
Suffering Primary blood pressure
Being Healthy Psychological
Did not have history of CVA and MI
Not having chronic diseases affecting quality of life
All patients are under the supervision of a doctor</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Get extensive information about managing blood pressure from other sources or changing the treatment protocol
Significant acute abnormalities and severe blood pressure or crisis
Patient death</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I10</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Essential (primary) hypertension</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After registration of patients who want to participate in research projects. The goals and the process of research will be explained to them. Patient's informed consent will be filled out. If they have inclusion criteria, they participate in the study. demographic information will be taken. This study was designed as a simple randomized controlled etrial with  one-to-one allocation into two groups. The intervention group participated in the EASE program will be 35 and control group too.The EASE program in six steps is as follows for the intervention group: During step 1 of this program, information about the participant’s demographic characteristics, treatment plan, and examination data was gathered. The appropriateness of each patient’s medical care was confirmed, and participants were evaluated to ensure their psychological and physical preparedness. Client–professional relationship a major inﬂuence on healthcare behaviors (Interaction model) (First session).  In Step 2, nurses encouraged participants to independently clarify issues related to their lifestyle and determine the self-management techniques needed for a healthier lifestyle (Express the positive and negative issues of lifestyle in relation to blood pressure), and Self-management approaches to improve healthy lifestyles (The factors and behaviors that reduce the blood pressure and its complications will be named and appropriate answers will be encouraged) ( Promotion model, Self efficacy) (second session). In Step 3, participants were involved in the setting of specific goals to foster self-efficacy and received support for their autonomous achievement of these goals, as enhanced self-efficacy is thought to lead to behavioral changes (Self efficacy, Promotion model) (second session). In step 4, techniques for achieving these goals were selected. In this study, self-monitoring was used to monitor the participants' actions and emotions toward their goals. The participants used self-monitoring techniques that involved monitoring of their actions and related benefits, which were logged using monitoring notes. Other techniques were added according to the participant’s condition; these included behavioral reinforcement and incremental goal achievement (action goals were set using small steps that initiated from achievable goals). Encouraging achievements, planning minor goals for achieving success and gaining positive experiences, encouraging verbal and nonverbal ways to increase repetition of behavior, creating optimism and hope for breakthroughs that will all enhance patient self-efficacy ( Promotion model, Self efficacy) (The third and fourth sessions). For Step 5, the nurses supported the participants' achievements of their action goals through interviews (fifth meeting) and phone or e-mail communication that patients will be contacted for 3-5 weeks every three days every 10 to 10 minutes, and guidance and encouragement will be used to strengthen positive behaviors and will support the achievements of the participants in achieving the desired goals (Promotion model, Self efficacy). For step 6: Achieving the desired goals will be evaluated. After eight weeks from the completion of the study, the variables will be re-evaluated as self-report at the clinic's meeting for re-examination (sixth session).</i_keyword>
      <i_keyword>35 patients will be in control group. The control group won't participate in education sessions. The control group will receive routine education based on health centers program according to national protocols. At the first, control group will receive self-management, and self-monitoring of blood pressure questionnaires. Blood tests, Body Mass Index, blood pressure, will be measured too. After 3 months, the questionnaires,  Clinical blood tests and BMI, blood pressure will be done again.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Blood pressure. Timepoint: All variables at baseline and at the end of 3 months are evaluated. Method of measurement: Manometer.</prim_outcome>
      <prim_outcome>BMI. Timepoint: All variables at baseline and  at the end of 3 months are evaluated. Method of measurement: Calibrated scale and meter.</prim_outcome>
      <prim_outcome>Nutritional status. Timepoint: All variables at baseline and at the end of 3 months are evaluated. Method of measurement: Questionnaire.</prim_outcome>
      <prim_outcome>Physical activity. Timepoint: All variables at baseline and then at the end of 3 months are evaluated. Method of measurement: Questionnaire.</prim_outcome>
      <prim_outcome>Paraclinic (Blood)tests: TG, cholestrol, Na of urine(24 hours). Timepoint: At baseline and at the end of 3 months are evaluated. Method of measurement: Labratory kits.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Self-management behaviors. Timepoint: At the beginning of the study and 3 months after the study. Method of measurement: Likert questionnaire.</sec_outcome>
      <sec_outcome>Self-care behaviors. Timepoint: At the beginning of the study and 3 months after the study. Method of measurement: Likert questionnaire.</sec_outcome>
      <sec_outcome>Self-regulation behaviors. Timepoint: At the beginning of the study and 3 months after the study. Method of measurement: Likert questionnaire.</sec_outcome>
      <sec_outcome>Self-monitoring behaviors. Timepoint: At the beginning of the study and 3 months after the study. Method of measurement: Likert questionnaire.</sec_outcome>
      <sec_outcome>Response to the disease. Timepoint: At the beginning of the study and 3 months after the study. Method of measurement: Likert questionnaire.</sec_outcome>
      <sec_outcome>Training EASE program. Timepoint: During the 3 months of intervention. Method of measurement: Not.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-09-26</approval_date>
        <contact_name>Ethics committee of Hamadan University of Medical Sciences</contact_name>
        <contact_address>Hamadan University of Medical Sciences, Shahid Fahmideh Av, Hamadan, Iran. Hamedan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
